⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PLSE News
Pulse Biosciences, Inc Common Stock (DE)
Pulse Biosciences, Inc. Announces First Enrollments in Feasibility Study for the Treatment of Malignant Thyroid Tumors with nPulse™ Technology
businesswire.com
PLSE
Form 8-K
sec.gov
PLSE
Pulse Biosciences to Present at the Oppenheimer 36 th Annual Healthcare MedTech & Services Conference
businesswire.com
PLSE
Pulse Biosciences’ nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting
businesswire.com
PLSE
Form 8-K
sec.gov
PLSE
Form 8-K/A
sec.gov
PLSE
Form 8-K
sec.gov
PLSE
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
PLSE
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
PLSE
Pulse Biosciences to Present at the 46 th Annual TD Cowen Healthcare Conference
businesswire.com
PLSE